Ex vivo purging of leukemia cells using tumor-necrosis-factor-related apoptosis-inducing ligand in hematopoietic stem cell transplantation. (Q53653814)

16 May 2018

title

Ex vivo purging of leukemia cells using tumor-necrosis-factor-related apoptosis-inducing ligand in hematopoietic stem cell transplantation. (English)

1 reference

16 May 2018

1 reference

Lee NS

1

1 reference

16 May 2018

Cheong HJ

2

1 reference

16 May 2018

Kim SJ

3

1 reference

16 May 2018

Kim SE

4

1 reference

16 May 2018

Kim CK

5

1 reference

16 May 2018

Lee KT

6

1 reference

16 May 2018

Park SK

7

1 reference

16 May 2018

Baick SH

8

1 reference

16 May 2018

Hong DS

9

1 reference

16 May 2018

Park HS

10

1 reference

16 May 2018

Won JH

11

1 reference

16 May 2018

publication date

1 July 2003

1 reference

16 May 2018

published in

Leukemia

1 reference

16 May 2018

volume

17

1 reference

16 May 2018

issue

7

1 reference

16 May 2018

page(s)

1375-1383

1 reference

16 May 2018

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402960

exact match

0 references

cites work

Autologous transplantation. Purging and the impact of minimal residual disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402960

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402960

Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402960

Pharmacological bone marrow purging in autologous transplantation: focus on the cyclophosphamide derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402960

The receptor for the cytotoxic ligand TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402960

Death receptors: signaling and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402960

Identification and characterization of a new member of the TNF family that induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402960

Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402960

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402960

The TRAIL to an anti-cancer agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402960

Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402960

Ex vivo purging of stem cell autografts using cytotoxic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402960

Retrovirus-mediated gene transfer as an approach to analyze neuroblastoma relapse after autologous bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402960

Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402960

TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402960

Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402960

Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402960

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402960

7 January 2021

Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402960

7 January 2021

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402960

7 January 2021

TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402960

7 January 2021

Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402960

7 January 2021

TRAIL: a molecule with multiple receptors and control mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402960

7 January 2021

Chemosensitivity of solid tumor cellsin vitro is related to activation of the CD95 system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402960

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402960

1 reference

16 May 2018

Dimensions Publication ID

0 references

1 reference

16 May 2018